Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Kite Pharma Inc.

Division of Gilead Sciences Inc.
www.kitepharma.com

Latest From Kite Pharma Inc.

Shaw Leaves Lilly To Helm Gilead’s Kite

After heading up Lilly Bio-Medicines for two-and-a-half years, Shaw will take over Gilead’s gene therapy subsidiary. At Lilly, she oversaw the approvals of Olumiant and Emgality and helped grow Taltz.

Business Strategies Leadership

EMA Explains When 'Out Of Specification' CAR-Ts Can Be Given To Patients

The European Medicines Agency must be informed about each 'out of specification' batch of a cell or tissue-based advanced therapy that has been granted marketing authorization. The agency warns that if a trend is discovered, it may consider the need for regulatory actions.
Europe Gene Therapy

Medicare CAR-T Coverage Decision Appears Hung Up In Political Review, Former CMS Official Says

Proliferation of expensive accelerated approval products requires "a revision to the existing evidence and policy approach for payers," Sean Tunis tells the DIA annual meeting.

Medicare Cancer

Q&A: SVP Elliott Levy On Amgen R&D's 'Singular Focus On Innovation'

Scrip spoke with Levy, senior vice president of global development, about the company's novel candidates for cardiovascular and inflammatory diseases and cancer, including modalities outside of its primary focus on biologics and small molecules.

Research and Development Strategies Cardiovascular
See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Large Molecule
  • Pharmaceuticals
    • Vaccines
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Gilead Sciences Inc.
  • Senior Management
  • Christi L Shaw, CEO
  • Contact Info
  • Kite Pharma Inc.
    Phone: (650) 574-3000
    333 Lakeside Dr.
    Foster City, CA 90404
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register